Diabetes-Associated Susceptibility to Tuberculosis: Contribution of Hyperglycemia vs. Dyslipidemia
- PMID: 34835407
- PMCID: PMC8620310
- DOI: 10.3390/microorganisms9112282
Diabetes-Associated Susceptibility to Tuberculosis: Contribution of Hyperglycemia vs. Dyslipidemia
Abstract
Diabetes is a major risk factor for tuberculosis (TB). Diabetes increases the risk of the progression from latent tuberculosis infection (LTBI) to active pulmonary TB and TB patients with diabetes are at greater risk of more severe disease and adverse TB treatment outcomes compared to TB patients without co-morbidities. Diabetes is a complex disease, characterised not only by hyperglycemia but also by various forms of dyslipidemia. However, the relative contribution of these underlying metabolic factors to increased susceptibility to TB are poorly understood. This review summarises our current knowledge on the epidemiology and clinical manifestation of TB and diabetes comorbidity. We subsequently dissect the relative contributions of body mass index, hyperglycemia, elevated cholesterol and triglycerides on TB disease severity and treatment outcomes. Lastly, we discuss the impact of selected glucose and cholesterol-lowering treatments frequently used in the management of diabetes on TB treatment outcomes.
Keywords: Mycobacterium tuberculosis; cholesterol; diabetes; dyslipidemia; hyperglycemia; triglycerides; tuberculosis.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
References
-
- World Health Organization . Global Tuberculosis Report 2020. World Health Organization; Geneva, Switzerland: 2020.
-
- Federation I.D. IDF Diabetes Atlas. [(accessed on 22 September 2021)]. Available online: https://www.diabetesatlas.org.
-
- World Health Organization . The Impact of the COVID-19 Pandemic on Noncommunicable Disease Resources and Services: Results of a Rapid Assessment. World Health Organization; Geneva, Switzerland: 2020.
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
